| Symbol | HIND |
|---|---|
| Name | VYOME HOLDINGS, INC |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 1001 CALLE AMANECER, SAN CLEMENTE, CA 92673 |
| Telephone | 949-429-6680 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001427570 |
| Description | None |
(30% Negative) VYOME HOLDINGS, INC (HIND) Reports Q2 2026 Financial Results
Read moreVyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet
Read moreVyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity
Read moreVyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
Read moreNew Form DEF 14A - Vyome Holdings, Inc <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001213900-26-036740 <b>Size:</b> 5 MB
Read moreVyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase
Read moreNew Form 10-K - Vyome Holdings, Inc <b>Filed:</b> 2026-03-18 <b>AccNo:</b> 0001213900-26-029500 <b>Size:</b> 11 MB
Read more